Shanghai ZJ Bio-Tech Co. Ltd. A688317
± MixedCapitalrelevance
Company repurchased shares and reported Q1 loss, mixed signals for investors.

Zhejiang Bio announced that as of July 31, 2026, the company had repurchased a total of 4.37 million shares, representing 2.30% of its total share capital, for a total amount of 85.92 million yuan, at prices ranging from 14.71 yuan to 23.49 yuan per share. In the first quarter of 2026, the company achieved operating revenue of 25.42 million yuan, with a net loss attributable to shareholders of the parent company of 25.51 million yuan.
Shanghai ZJ Bio-Tech Co. Ltd. ACompany repurchased shares and reported Q1 loss, mixed signals for investors.